Replies to post #102547 on Biotech Values

[ThomasS]

MNTA: "while I hope you are correct, however my pragmatic side says this market needs to see definitive proof that Sandoz is successful with sales at a decent margin."
{You presumably don't believe management's commentary regarding 35-40% market penetration at this early juncture post-launch? What reasons do you have to suspect anything less than excellent margins?}
{Your "pragmatic side" needn't be concerned if you sell your MNTA shares today and sleep well at night, eh?}

"2nd there is a lot of chatter that TEVA approval is right around the corner."
{Yes, and we heard the same about MNTA's "pending approval" for 2 years; thus, what is your point? Believe the chatter and buy TEVA, otherwise, please stop pounding us with such dribble. All of us are fully aware of TEVA's pending application.}